Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Benefits, limits and safety aspects

Phytotherapy for cardiovascular diseases

    • RX
    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • Pharmaceutical medicine
    • Phytotherapy
    • Studies
  • 8 minute read

Herbal preparations and “natural” dietary supplements are frequently used by patients with cardiovascular disease – often in the hope of “gently” influencing blood pressure, lipids or symptoms. However, guidelines from European and American professional societies unanimously emphasize that phytotherapeutics and dietary supplements should not replace established lifestyle and pharmacotherapy. In particular, the 2025 focused ESC/EAS update on dyslipidemia therapy concludes, after reviewing the available evidence, that there is insufficient evidence for any supplement that lowers LDL cholesterol while improving cardiovascular risk with reasonable safety.

Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich
Jetzt beitreten
Already a member? Log in here
Autoren
  • Tanja Schliebe
Publikation
  • PHYTOTHERAPIE PRAXIS
Related Topics
  • ESC/EAS
  • Focus adjustment
  • Food supplement
  • LDL cholesterol
  • red rice
Previous Article
  • Results of the FOREST HCM study

Symptomatic obstructive hypertrophic cardiomyopathy

  • RX
  • Cardiology
  • Education
  • Studies
View Post
Next Article
  • Digital biomarkers

Continuous monitoring using digital biomarkers in MS care

  • RX
  • Education
  • Neurology
  • Studies
View Post
You May Also Like
View Post
  • 4 min
  • Hypertension: the most important facts for daily practice

Early dual antihypertensive therapy is usually indicated

    • RX
    • Cardiology
    • Congress Reports
    • General Internal Medicine
View Post
  • 4 min
  • Escitalopram for anxiety disorders

Positive effect, but no immediate improvement in symptoms

    • RX
    • Education
    • Neurology
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • Studies
View Post
  • 4 min
  • Helicobacter pylori infection

Simplified dual therapy beats quadruple regimen

    • RX
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Infectiology
    • Studies
View Post
  • 3 min
  • Gastric carcinoma

Ways of precision oncology

    • RX
    • Congress Reports
    • Gastroenterology and Hepatology
    • Oncology
    • Studies
View Post
  • 8 min
  • Endometrial Cancer

Immunological drivers and new therapeutic pathways

    • RX
    • Education
    • Gynecology
    • Oncology
    • Studies
View Post
  • 6 min
  • Exercise for type 1 diabetes

Cyclists and runners with an increased risk of hypoglycemia

    • RX
    • Education
    • Endocrinology and Diabetology
    • Sports Medicine
    • Studies
View Post
  • 4 min
  • Ozanimod for relapsing-remitting multiple sclerosis

Signs of improved tolerability with prolonged treatment

    • RX
    • Education
    • Neurology
    • Pharmacology and toxicology
    • Studies
View Post
  • 8 min
  • When basal cell carcinomas prove difficult to treat

Reaching the goal with innovative therapy strategies

    • RX
    • Cases
    • Congress Reports
    • Dermatology and venereology
    • Oncology
    • Studies
    • Surgery
Landingpage Fachinfo Landingpage Button
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Communication as the key to therapy adherence
  • 2
    Solutions to the malnutrition dilemma
  • 3
    Solutions to the malnutrition dilemma
  • 4
    Focus on preventive care options
  • 5
    Fertility preservation from gonads to genomes to genoids

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.